Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTRA-2112 for gastrointestinal maturation in preterm infants
2014-002624-28Phase 3Terminated
- Sponsor
- Nutrinia
- Start
- Aug 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in feeding intolerance and Gastrointestinal immaturity comparing NTRA-2112 with Placebo (2 arms). Primary endpoint: Number of days to achieve complete enteral feeding. Started Aug 2014; status: terminated.
02
Drugs
elgn-gi
03
Conditions
feeding intoleranceGastrointestinal immaturity
Beyond the preview
Go deeper on 2014-002624-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002624-28.